Community Contributor
Member since 2019
Views
34 Total number of views
Fair Values Set
0 Total number of fair values set
Comments
0 Total number of comments
Followers
0 Total number of followers

No bio added yet

No link added
PPGN logo
PolyPeptide Group

Biotech longerterm bet

211011 Draupnir noch ein Anteil von rund 55,5% an Polypeptide. Der «Free Float» an der Börse SIX erhöht sich dadurch gleichzeitig von 40,0 auf rund 44,5%.Read more

View narrative
CHF 33.1
19.0% overvalued intrinsic discount
Fair Value
Profit Margin
13.61%
Future PE
18.34x
Price in 2029
CHF 41.33